Search details
1.
Systemic glucocorticoid use and the occurrence of flares in psoriatic arthritis and psoriasis: a systematic review.
Rheumatology (Oxford)
; 61(11): 4232-4244, 2022 11 02.
Article
in English
| MEDLINE | ID: mdl-35285486
2.
Do Patients with Psoriatic Arthritis Have More Severe Skin Disease than Patients with Psoriasis Only? A Systematic Review and Meta-Analysis.
Dermatology
; 238(6): 1108-1119, 2022.
Article
in English
| MEDLINE | ID: mdl-35551372
3.
IMO-8400, a toll-like receptor 7, 8, and 9 antagonist, demonstrates clinical activity in a phase 2a, randomized, placebo-controlled trial in patients with moderate-to-severe plaque psoriasis.
Clin Immunol
; 174: 63-72, 2017 01.
Article
in English
| MEDLINE | ID: mdl-27876460
4.
More on Mu-Opioid Receptor Antagonists in PD-1 BlockadeInduced Pruritus.
N Engl J Med
; 380(6): 601, 2019 02 07.
Article
in English
| MEDLINE | ID: mdl-30730693
5.
Weighing in on weight-based secukinumab dosing for psoriasis.
Br J Dermatol
; 187(1): 10-11, 2022 07.
Article
in English
| MEDLINE | ID: mdl-35575459
6.
Anti-interleukin-17A for pityriasis rubra pilaris: catching the psoriasis biologic wave.
Br J Dermatol
; 187(5): 633-634, 2022 11.
Article
in English
| MEDLINE | ID: mdl-35996840
7.
Combination Therapy of Etanercept and Fumarates versus Etanercept Monotherapy in Psoriasis: A Randomized Exploratory Study.
Dermatology
; 232(4): 407-14, 2016.
Article
in English
| MEDLINE | ID: mdl-27576483
8.
Anti-Interleukin-31 Receptor A Antibody for Atopic Dermatitis.
N Engl J Med
; 376(21): 2092, 2017 05 25.
Article
in English
| MEDLINE | ID: mdl-28541012
9.
A benchmark for comparison of cell tracking algorithms.
Bioinformatics
; 30(11): 1609-17, 2014 Jun 01.
Article
in English
| MEDLINE | ID: mdl-24526711
10.
Early identification of atopic dermatitis patients in need of systemic immunosuppressive treatment.
Clin Exp Allergy
; 49(12): 1641-1644, 2019 12.
Article
in English
| MEDLINE | ID: mdl-31520450
11.
Is mipomersen ready for clinical implementation? A transatlantic dilemma.
Curr Opin Lipidol
; 24(4): 301-6, 2013 Aug.
Article
in English
| MEDLINE | ID: mdl-23759796
12.
Patient-Reported Outcome Measures for Health-Related Quality of Life in Patients With Psoriasis: A Systematic Review.
JAMA Dermatol
; 160(5): 550-563, 2024 May 01.
Article
in English
| MEDLINE | ID: mdl-38265774
13.
Topical trifarotene: a new retinoid.
Br J Dermatol
; 179(2): 231-232, 2018 08.
Article
in English
| MEDLINE | ID: mdl-30141539
14.
Prevalence of cutaneous adverse events associated with long-term disease-modifying therapy and their impact on health-related quality of life in patients with multiple sclerosis: a cross-sectional study.
BMC Neurol
; 13: 146, 2013 Oct 16.
Article
in English
| MEDLINE | ID: mdl-24131589
15.
Cutaneous adverse events associated with disease-modifying treatment in multiple sclerosis: a systematic review.
Mult Scler
; 18(12): 1705-17, 2012 Dec.
Article
in English
| MEDLINE | ID: mdl-22371220
16.
Non-Alcoholic Fatty Liver Disease (NAFLD) in Patients with Psoriasis: A Review of the Hepatic Effects of Systemic Therapies.
Psoriasis (Auckl)
; 11: 151-168, 2021.
Article
in English
| MEDLINE | ID: mdl-34909410
17.
[Chronic itch]. / Chronische jeuk.
Ned Tijdschr Geneeskd
; 1652021 01 21.
Article
in Dutch
| MEDLINE | ID: mdl-33651503
18.
Cost per PASI-75 responder of calcipotriol plus betamethasone dipropionate cutaneous foam versus nonbiologic systemic therapies for the treatment of plaque psoriasis in seven European countries.
J Dermatolog Treat
; 32(7): 701-708, 2021 Nov.
Article
in English
| MEDLINE | ID: mdl-31940225
19.
Tissue-Resident Memory CD8+ T Cells From Skin Differentiate Psoriatic Arthritis From Psoriasis.
Arthritis Rheumatol
; 73(7): 1220-1232, 2021 07.
Article
in English
| MEDLINE | ID: mdl-33452865
20.
Long-term Safety of Oral Systemic Therapies for Psoriasis: A Comprehensive Review of the Literature.
Dermatol Ther (Heidelb)
; 10(4): 589-613, 2020 Aug.
Article
in English
| MEDLINE | ID: mdl-32529393